News
2d
Medindia on MSNClimate Change Might Be the New Carcinogen for WomenRising temperatures are linked to increases in the prevalence and mortality of breast, ovarian, uterine, and cervical cancers ...
Tolerability remained consistent, with fewer treatment discontinuations due to adverse events among pre-menopausal patients 1 Rising breast cancer diagnosis rates and more aggressive disease in ...
NEW YORK, DE, UNITED STATES, June 4, 2025 /EINPresswire.com/ -- The global digital breast tomosynthesis (DBT) equipment market is estimated to be valued at USD 3.26 billion in 2025 and is projected to ...
5d
News Medical on MSNNew visualisation tool helps researchers to target breast cancer disseminationCancer cell movement during metastasis is a dynamic process regulated by several different signals. However, the way cells receive, process and respond to these signals has been extremely hard to ...
The Boob Bus Partners With Cigna Healthcare to Expand Access to Breast Cancer Screenings Across Utah
Serving More Than 1900 Utah Women Since Its Launch, The Boob Bus Continues To Expand Access To Breast Cancer Screening With ...
Dr. Reddy's Laboratories and Alvotech are collaborating to develop, manufacture, and commercialize a biosimilar version of ...
Learn how radiopharmaceuticals are transforming nuclear medicine and cancer therapy through targeted diagnostics and ...
Discover the major highlights from ASCO 2025, according to researchers and drug developers who attended the convention.
CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company") announced today that it ...
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that its genome-based ...
Topline data from Clarity's diagnostic Phase II trial, DISCO, confirms that 64 Cu-SARTATE is safe and highly effective ...
Optiscan CEO Dr. Camile Farah delves into the company’s technology and capabilities that have positioned it as a leader ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results